GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Accounts Payable & Accrued Expense

GemVax & KAEL Co (XKRX:082270) Accounts Payable & Accrued Expense : ₩7,112 Mil (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Accounts Payable & Accrued Expense?

GemVax & KAEL Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (₩12,327 Mil) to Dec. 2024 (₩12,147 Mil) and declined from Dec. 2024 (₩12,147 Mil) to Mar. 2025 (₩7,112 Mil).

GemVax & KAEL Co's annual accounts payable & accrued expense increased from Dec. 2022 (₩4,724 Mil) to Dec. 2023 (₩4,957 Mil) and increased from Dec. 2023 (₩4,957 Mil) to Dec. 2024 (₩12,147 Mil).


GemVax & KAEL Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for GemVax & KAEL Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Accounts Payable & Accrued Expense Chart

GemVax & KAEL Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,196.12 3,933.15 4,723.57 4,957.31 12,147.09

GemVax & KAEL Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16,015.40 11,988.82 12,327.12 12,147.09 7,112.05

GemVax & KAEL Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


GemVax & KAEL Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co Headlines

No Headlines